Guangdong releases expert consensus on thyroid cancer genetic testing and clinical application for the first time

cell moleculardiagnosticcenter staff is cutting specimens to do genetic testing hospital forSun Yat-sen Memorial Hospital of Zhongshan University, said on the 22nd, by the hospital's director of thyroid surgery Li Honghao and the deputy director of the cell molecular diagnostic center Ouyang Nengtai led the "thyroid cancer genetic detection and clinical application of Guangdong expertsconsensus(2020 version) has been releaseddifferent from the traditional diagnosis and treatment mode of thyroid nodules, the above-mentioned Consensus involvesprecisiondiagnosis and individual treatment plan development, for thyroid tumor patients to develop accurate individualizedmanagementprogram, including genetic detection in thyroid nodule malignancy, personalized treatment, genetic thyroid cancerscreeningand targeted treatment, and how to do genetic testing, detection of which genesthyroid cancer is the fastest growing malignant tumor in recent yearsAccording to data released by the National Cancer Center, the incidence of thyroid cancer among women in urban areas in the Mainland is the fourth highest among all malignant tumors in womenThyroid cancer malignant degree and treatment methods vary, from the genetic level of the tumor to understand the pathogenesis of thyroid cancer, screening low-risk thyroid cancer and high-risk thyroid cancer, the establishment of accurate, standardized, personalized management model or become the general trend Li Honghao, of the , with the enhancement of people's awareness of health check-ups, more and more small thyroid papilloma cancer was found, however, "small cancer" is not equal to "low-risk cancer", aggressive micro-cancer early has occurred neck lymphatic metastasis cases are not uncommon, for small thyroid papilloma carcinoma, currently including active observation, ablation, surgery and other treatment programs, including different degrees of malignant thyroid cancer surgery scope is different "thyroid cancer needs to adhere to the principle of 'early prevention , early detection, early treatment' Li Honghao said that the release of the Consensus is of great significance for finding a reasonable way to assess thyroid cancer and accurately judging the clinical difficulties of low-risk or high-risk thyroid cancer "In thyroid cancer, most benign nodules do not require surgical treatment, and inaccurate oversurgery can lead to many disadvantages such as life-long medication Genetic testing can help accurately identify the fine and malignant thyroid nodules, so that patients avoid overtreatment while taking into account the standardization of radical cure Ouyang can be too said, in addition, genetic testing can accurately screen out hereditary thyroid cancer, hereditary thyroid myelin cancer malignant degree is relatively high, early screening of asymptomatic gene mutation patients, early timely treatment, can save the patient's life Ouyang Nengtai said that compared to other malignant tumor genetic testing generally carried out after surgery, thyroid genetic testing is generally carried out before surgery, the main purpose is to identify the thyroid nodules and assess the ability of tumor invasion, the final decision whether surgery and surgery scope (Complete) Yuanyuan Source: China News